Enovix says roughly $100M estimate is not guidance
Enovix expects to provide updated financial guidance with its third-quarter 2026 results on November 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Enovix Corporation (ENVX) clarified that an article-reported estimate of around $100 million in 2027 revenue was not a company-authorized disclosure and should not be relied on as company guidance. The company said the shipments described in The Electric’s October 21, 2026 article went to a smart eyewear customer, not a smartphone maker.
Enovix said it had shipped approximately 17,000 production sample cells to that customer as of the end of the third quarter of 2026, out of a 50,000 pack order. It said its $216 million drone, defense and industrial pipeline as of quarter-end is expected to be the primary driver of revenue growth, and it expects to provide updated guidance with third-quarter results on November 12, 2026.
8-K Event Classification
Item 7.01 — Regulation FD Disclosure
1 item
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Key Figures
Article-reported 2027 revenue estimate: around $100 million
Drone, defense and industrial pipeline: $216 million
Production sample cells shipped: approximately 17,000 cells
+1 more
4 metrics
Article-reported 2027 revenue estimate
around $100 million
Enovix said the estimate was not a company-authorized disclosure and should not be relied on as company guidance.
Drone, defense and industrial pipeline
$216 million
As of the end of the third quarter of 2026.
Production sample cells shipped
approximately 17,000 cells
Shipped to a smart eyewear customer as of the end of the third quarter of 2026.
Customer order
50,000 pack order
Order associated with the smart eyewear customer.
Key Terms
production sample cells, pack order, pipeline, forward-looking statements
4 terms
production sample cells technical
"approximately 17,000 production sample cells"
pack order technical
"out of a 50,000 pack order"
pipeline financial
"drone, defense and industrial pipeline"
A pipeline is the organized list of products, drugs or projects a company is developing but has not yet fully launched or commercialized. For investors it acts like a forecasted inventory of future revenue sources — showing what could become earnings, how far along each item is, and the risk and time before they might pay off; think of it as a company’s product roadmap that helps gauge growth potential and uncertainty.
forward-looking statements regulatory
"This report contains forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Did ENVX give $100 million revenue guidance for 2027?
Enovix said the estimate of around $100 million in 2027 revenue attributed to an officer in The Electric’s October 21, 2026 article was not a company-authorized disclosure and should not be relied on as company guidance. Enovix expects to provide updated guidance with third-quarter 2026 results on November 12, 2026.
How many cells had ENVX shipped to its smart eyewear customer?
Enovix said it had shipped approximately 17,000 production sample cells to a smart eyewear customer as of the end of the third quarter of 2026, out of a 50,000 pack order.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2026
(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
Registrant’s Telephone Number, Including Area Code: (510 ) 695-2350
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On October 21, 2026, The Electric published an article in which an officer of Enovix Corporation (the “Company”) stated that the Company “estimated that 2027 revenue will be around $100 million”, and that “[most] of that [revenue] … will be from smartphone customers ….”, and that Enovix “had shipped 50,000 cells to a smartphone maker that was prototyping a new model ….”
The 2027 estimated revenue disclosed in the article was not a Company-authorized disclosure, and investors should not rely on those statements as Company guidance for 2027. The Company expects to provide its updated financial guidance when it releases its third quarter 2026 financial results on November 12, 2026. The Company notes that its current expectation is that revenue growth will be primarily driven by its drone, defense and industrial pipeline, which was $216 million as of the end of the third quarter of 2026, as previously disclosed by the Company. The Company also would like to clarify that the shipments referenced in the article were to a smart eyewear customer, not a smartphone maker, and that, as previously disclosed, the Company had shipped approximately 17,000 production sample cells to that customer as of the end of the third quarter of 2026, out of a 50,000 pack order.
The information in this report is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
This Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or our future financial or operating performance and are identified by words such as anticipate, believe, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, will, would and similar expressions. Forward-looking statements in this Form 8-K include, but are not limited to, statements regarding the expected timing of the release of the Company’s third quarter 2026 financial results and updated guidance, and the Company’s expectation that its revenue growth will be primarily driven by its drone, defense and industrial pipeline. Risks, uncertainties and assumptions that could cause actual results to differ materially from the results and events anticipated by such forward-looking statements include risks relating to the Company’s expected drone, defense and industrial pipeline and the conversion of that pipeline into revenue, the timing of the release of the Company’s third quarter 2026 financial results, and other risks described in the disclosures contained in the Company’s filings with the Securities and Exchange Commission (“SEC”), including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of its annual report on Form 10-K and quarterly reports on Form 10-Q, and other documents that its has filed, or will file, with the SEC. Any forward-looking statements in this Form 8-K speak only as of the date on which they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Enovix Corporation | |||||||||||
| Date: | October 22, 2026 | By: | /s/ Arthi Chakravarthy | ||||||||
Arthi Chakravarthy Chief Legal Officer | |||||||||||